Novartis signs deal to bring CAR T therapy to China

01-10-2018

Novartis signs deal to bring CAR T therapy to China

posteriori / iStockphoto.com

Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China.


Novartis, Cellular Biomedicine Group, CAR T therapy, oncology, cancer treatment, Kymriah, China, licensing agreement, collaboration, biopharmaceutical

LSIPR